Pilar Paniagua

Dr. Pilar Paniagua

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
ZPZubin Punthakee
Zubin Punthakee
Pilar PaniaguaPilar Paniagua
Pilar Paniagua
PAPablo Alonso
Pablo Alonso
IGIgnasi Gich
Ignasi Gich
IIInmaculada India
Inmaculada India
PDP J Devereaux
P J Devereaux

18 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EJElena Jimenez-Xarrie
Elena Jimenez-Xarrie
LALluís Asmarats
Lluís Asmarats
MRMarta Roqué-Figuls
Marta Roqué-Figuls
XMXavier Millán
Xavier Millán
CLChi Hion Pedro Li
Chi Hion Pedro Li
DADabit Arzamendi
Dabit Arzamendi
Transcatheter aortic valve replacement (TAVR) is currently the treatment of choice for patients aged ≥75 years with severe aortic stenosis. Preoperative anemia is present in a large proportion of patients and may increase the risk of post-procedural complications. The purpose of this prognostic systematic review was to analyze the impact of baseline anemia on short- and mid-term outcomes following TAVR. A computerized search was performed on PubMed and Web of Science databases for studies published between January 2013 and December 2022. Primary outcomes were 30-day need for transfusion, acute renal failure, 30-day and mid-term mortality, and readmission during the first year post-TAVR. Data were analyzed via random effects model using inverse variance method with 95% confidence intervals. Eleven observational studies met our eligibility criteria and included a total of 12,588 patients. The prevalence of baseline anemia ranged between 39% and 72%, with no relevant sex differences. Patients with preprocedural anemia received more blood transfusions [OR: 2.95 (2.13–4.09)]), and exhibited increased rates of acute kidney injury [OR:1.74 (1.45–2.10)], short-term mortality [OR: 1.47 (1.07–2.01], and mid-term [OR: 1.89 (1.58–2.25)] mortality following TAVR compared with those without anemia. Baseline anemia determined an increased risk for blood transfusion, acute kidney injury, and short/mid-term mortality among TAVR recipients.

18 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EPEkaterine Popova
Ekaterine Popova
Pilar PaniaguaPilar Paniagua
Pilar Paniagua
JAJesus Alvarez-Garcia
Jesus Alvarez-Garcia
MVMiquel Vives-Borrás
Miquel Vives-Borrás
AGAranzazú González
Aranzazú González
PAPablo Alonso
Pablo Alonso
Perioperative myocardial injury (PMI) is a common cardiac complication. Recent guidelines recommend its systematic screening using high-sensitivity cardiac troponin (hs-cTn). However, there is limited evidence of local screening programs. We conducted a prospective, single-center study aimed at assessing the feasibility and outcomes of implementing systematic PMI screening. Hs-cTn concentrations were measured before and after surgery. PMI was defined as a postoperative hs-cTnT of ≥14 ng/L, exceeding the preoperative value by 50%. All patients were followed-up during the hospitalization, at one month and one year after surgery. The primary outcome was the incidence of death and major cardiovascular and cerebrovascular events (MACCE). The secondary outcomes focused on the individual components of MACCE. We included two-thirds of all eligible high-risk patients and achieved almost complete compliance with follow-ups. The prevalence of PMI was 15.7%, suggesting a higher presence of cardiovascular (CV) antecedents, increased perioperative CV complications, and higher preoperative hs-cTnT values. The all-cause death rate was 1.7% in the first month, increasing up to 11.2% at one year. The incidence of MACCE was 9.5% and 8.6% at the same time points. Given the observed elevated frequencies of PMI and MACCE, implementing systematic PMI screening is recommendable, particularly in patients with increased cardiovascular risk. However, it is important to acknowledge that achieving optimal screening implementation comes with various challenges and complexities.


1 October 2014 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
Pilar PaniaguaPilar Paniagua
Pilar Paniagua
SRSusana Díaz Ruano
Susana Díaz Ruano
JAJesus Alvarez-Garcia
Jesus Alvarez-Garcia

1 March 2013 in Revista Española de Anestesiología y Reanimación
Verified
Journal Article
Closed access
Pilar PaniaguaPilar Paniagua
Pilar Paniagua
GFG. Fita
G. Fita
LRL. Rivera
L. Rivera
FPF. Parramon
F. Parramon
TKT. Koller
T. Koller
XMX. March
X. March